(3aR,3'aR,8aS,8'aS)-2,2'-Cyclopentylidenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole]
(3aR,3'aR,8aS,8'aS)-2,2'-Cyclopentylidenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole] Basic information
- Product Name:
- (3aR,3'aR,8aS,8'aS)-2,2'-Cyclopentylidenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole]
- Synonyms:
-
- (3aR,3'aR,8aS,8'aS)-2,2'-Cyclopentylidenebis[3a,8a-dihydr o-8H-indeno[1,2-d]oxazole],99%e.e.
- (3aR,3'aR,8aS,8'aS)-2,2'-Cyclopentylidenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole]
- (3aR,3'aR,8aS,8'aS)-2,2'-Cyclopentylidenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole] 98%, (99% ee)
- SF140017
- 8H-Indeno[1,2-d]oxazole, 2,2'-cyclopentylidenebis[3a,8a-dihydro-, (3aR,3'aR,8aS,8'aS)-
- (3aR,3a'R,8aS,8a'S)-2,2'-(cyclopentane-1,1-diyl)bis(3a,8a-dihydro-8H-indeno[1,2-d]oxazole)
- (3aR,3'aR,8aS,8'aS)-2,2'-Cyclopentylidenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole
- CAS:
- 2005443-90-1
- MF:
- C25H24N2O2
- MW:
- 384.47
- Mol File:
- 2005443-90-1.mol
More
Less
(3aR,3'aR,8aS,8'aS)-2,2'-Cyclopentylidenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole] Chemical Properties
- Boiling point:
- 539.7±50.0 °C(Predicted)
- Density
- 1.46±0.1 g/cm3(Predicted)
- storage temp.
- under inert gas (nitrogen or Argon) at 2-8°C
- pka
- 5.88±0.20(Predicted)
(3aR,3'aR,8aS,8'aS)-2,2'-Cyclopentylidenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole]Supplier
Daicel Chiral Technologies (China)CO.,LTD
- Tel
- 021-50460086-9 15921403865
- han_yajun@dctc.daicel.com
Tianjin Derchemist Science & Technology Co., Ltd.
- Tel
- 22-58627059 13920586291
- zdcomcon@126.com
Bide Pharmatech Ltd.
- Tel
- 400-1647117 15221909166
- product02@bidepharm.com
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd.
- Tel
- 025-66113011 18112977050
- cb6@aikonchem.com
Shanghai Chiral bio-compound co., Ltd.
- Tel
- 021-5068 3667/17749785980/1029026415; 17749785980
- 1029026415@qq.com
More
Less
(3aR,3'aR,8aS,8'aS)-2,2'-Cyclopentylidenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole](2005443-90-1)Related Product Information
- (3aR,3'aR,8aS,8'aS)-2,2'-Cyclobutylidenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole]
- (3aS,3a'S,8aR,8a'R)-2,2'-(1,3-Diphenylpropane-2,2-diyl)bis(8,8a-dihydro-3aH-indeno[1,2-d]oxazole)
- (+)-2,2'-METHYLENEBIS[(3AR,8AS)-3A,8A-DIHYDRO-8H-INDENO[1,2-D]OXAZOLE]
- (3aR,3'aR,8aS,8'a'S)-2,2'-cyclopropylidenebis[3a,8a-dihydro-8H-Indeno[1,2-d]oxazole
- (-)-2,2'-METHYLENEBIS[(3AS,8AR)-3A,8A-DIHYDRO-8H-INDENO[1,2-D]OXAZOLE]
- (3aR,3a'R,8aS,8a'S)-2,2'-(1,3-diphenylpropane-2,2-diyl)bis(3a,8a-dihydro-8H-indeno[1,2-d]oxazole)
- (3aS,3'aS,8aR,8'a'R)-2,2'-cyclopropylidenebis[3a,8a-dihydro-8H-Indeno[1,2-d]oxazole
- (4S,4'S)-2,2'-[2-Phenyl-1-(phenylmethyl)ethylidene]bis[4- (1-methylethyl)-4,5-dihydrooxazole]
- (3aS,3'aS,8aR,8'aR)-2,2'-[2-[4-(1,1- dimethylethyl)phenyl]-1-[[4-(1,1- dimethylethyl)phenyl]methyl]ethylidene]bis[3a,8 a-dihydro-8H-Indeno[1,2-d]oxazole
- (3aS,3'aS,8aR,8'aR)-2,2'-Cyclopentylidenebis[3a,8a-dihydr o-8H-indeno[1,2-d]oxazole]